Free Trial

LifeVantage Co. Plans Quarterly Dividend of $0.04 (NASDAQ:LFVN)

LifeVantage logo with Medical background

LifeVantage Co. (NASDAQ:LFVN - Get Free Report) announced a quarterly dividend on Monday, February 3rd,RTT News reports. Stockholders of record on Monday, March 3rd will be paid a dividend of 0.04 per share on Monday, March 17th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date of this dividend is Monday, March 3rd.

LifeVantage has a dividend payout ratio of 15.4% meaning its dividend is sufficiently covered by earnings.

LifeVantage Stock Performance

LFVN traded up $0.32 during trading on Friday, reaching $19.31. 580,134 shares of the stock were exchanged, compared to its average volume of 317,488. The stock's 50 day moving average price is $19.33 and its two-hundred day moving average price is $13.83. LifeVantage has a twelve month low of $5.22 and a twelve month high of $27.38. The stock has a market cap of $242.34 million, a P/E ratio of 34.48 and a beta of 0.84.

LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

Analyst Upgrades and Downgrades

Several analysts recently commented on LFVN shares. Lake Street Capital started coverage on shares of LifeVantage in a report on Thursday, December 19th. They set a "buy" rating and a $26.00 target price for the company. Craig Hallum assumed coverage on LifeVantage in a research report on Tuesday, January 14th. They issued a "buy" rating and a $35.00 target price on the stock.

View Our Latest Research Report on LFVN

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Recommended Stories

Dividend History for LifeVantage (NASDAQ:LFVN)

Should You Invest $1,000 in LifeVantage Right Now?

Before you consider LifeVantage, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeVantage wasn't on the list.

While LifeVantage currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines